Compounds > 5,7-dichlorokynurenic acid
Page last updated: 2024-10-21

5,7-dichlorokynurenic acid and Constriction, Pathological

5,7-dichlorokynurenic acid has been researched along with Constriction, Pathological in 1 studies

5,7-dichlorokynurenic acid: potent antagonist at the N-methyl-D-aspartate receptor-associated glycine binding site

Research Excerpts

ExcerptRelevanceReference
"The importance of this mechanism in neuropathic pain remains unclear."1.33Antiallodynic effects of NMDA glycine(B) antagonists in neuropathic pain: possible peripheral mechanisms. ( Chizh, BA; Christoph, T; Englberger, W; Reissmüller, E; Schiene, K, 2005)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Christoph, T1
Reissmüller, E1
Schiene, K1
Englberger, W1
Chizh, BA1

Other Studies

1 other study available for 5,7-dichlorokynurenic acid and Constriction, Pathological

ArticleYear
Antiallodynic effects of NMDA glycine(B) antagonists in neuropathic pain: possible peripheral mechanisms.
    Brain research, 2005, Jun-28, Volume: 1048, Issue:1-2

    Topics: Action Potentials; Animals; Constriction, Pathologic; Disease Models, Animal; Dose-Response Relation

2005